From: The quality of primary care provided to the elderly in Israel

Influenza vaccination | ||||||||||

Male | Female | Total | ||||||||

SEP | Age | Numerator | Denominator | Rate | Numerator | Denominator | Rate | Numerator | Denominator | Rate |

Low SEP | 65–74 | 45,214 | 70,197 | 64.41% | 54,684 | 94,383 | 57.94% | 99,898 | 164,580 | 60.70% |

75–84 | 35,469 | 50,525 | 70.20% | 47,185 | 75,635 | 62.39% | 82,654 | 126,160 | 65.52% | |

85 or above | 12,234 | 16,742 | 73.07% | 21,008 | 32,913 | 63.83% | 33,242 | 49,655 | 66.95% | |

total | 92,917 | 137,464 | 67.59% | 122,877 | 202,931 | 60.55% | 215,794 | 340,395 | 63.40% | |

Middle & high SEP | 65–74 | 93,556 | 156,522 | 59.77% | 97,471 | 167,895 | 58.05% | 191,027 | 324,417 | 58.88% |

75–84 | 50,355 | 69,352 | 72.61% | 59,586 | 87,697 | 67.95% | 109,941 | 157,049 | 70.00% | |

85 or above | 16,090 | 22,154 | 72.63% | 23,503 | 35,656 | 65.92% | 39,593 | 57,810 | 68.49% | |

total | 160,001 | 248,028 | 64.51% | 180,560 | 291,248 | 62.00% | 340,561 | 539,276 | 63.15% | |

Total | 252,918 | 385,492 | 65.61% | 303,437 | 494,179 | 61.40% | 556,355 | 879,671 | 63.25% | |

Pneumococcal vaccination | ||||||||||

Male | Female | Total | ||||||||

SEP | Age | Numerator | Denominator | Rate | Numerator | Denominator | Rate | Numerator | Denominator | Rate |

Low SEP | 65–74 | 49,631 | 59,066 | 84.03% | 60,870 | 77,072 | 78.98% | 110,501 | 136,138 | 81.17% |

75–84 | NA | NA | NA | NA | NA | NA | NA | NA | NA | |

85 or above | NA | NA | NA | NA | NA | NA | NA | NA | NA | |

total | 49,631 | 59,066 | 84.03% | 60,870 | 77,072 | 78.98% | 110,501 | 136,138 | 81.17% | |

Middle & high SEP | 65–74 | 164,901 | 208,638 | 79.04% | 181,131 | 240,636 | 75.27% | 346,032 | 449,274 | 77.02% |

75–84 | NA | NA | NA | NA | NA | NA | NA | NA | NA | |

85 or above | NA | NA | NA | NA | NA | NA | NA | NA | NA | |

total | 164,901 | 208,638 | 79.04% | 181,131 | 240,636 | 75.27% | 346,032 | 449,274 | 77.02% | |

Total | 214,532 | 267,704 | 80.14% | 242,001 | 317,708 | 76.17% | 456,533 | 585,412 | 77.98% | |

Benzodiazepine overuse | ||||||||||

Male | Female | Total | ||||||||

SEP | Age | Numerator | Denominator | Rate | Numerator | Denominator | Rate | Numerator | Denominator | Rate |

Low SEP | 65–74 | 2698 | 70,197 | 3.84% | 4350 | 94,383 | 4.61% | 7048 | 164,580 | 4.28% |

75–84 | 3435 | 50,525 | 6.80% | 6775 | 75,635 | 8.96% | 10,210 | 126,160 | 8.09% | |

85 or above | 2021 | 16,742 | 12.07% | 4562 | 32,913 | 13.86% | 6583 | 49,655 | 13.26% | |

total | 8154 | 137,464 | 5.93% | 15,687 | 202,931 | 7.73% | 23,841 | 340,395 | 7.00% | |

Middle & high SEP | 65–74 | 2639 | 156,522 | 1.69% | 4880 | 167,895 | 2.91% | 7519 | 324,417 | 2.32% |

75–84 | 2888 | 69,352 | 4.16% | 5848 | 87,697 | 6.67% | 8736 | 157,049 | 5.56% | |

85 or above | 1721 | 22,154 | 7.77% | 4041 | 35,656 | 11.33% | 5762 | 57,810 | 9.97% | |

total | 7248 | 248,028 | 2.92% | 14,769 | 291,248 | 5.07% | 22,017 | 539,276 | 4.08% | |

Total | 15,402 | 385,492 | 4.00% | 30,456 | 494,179 | 6.16% | 45,858 | 879,671 | 5.21% | |

Long-term benzodiazepine | ||||||||||

Male | Female | Total | ||||||||

SEP | Age | Numerator | Denominator | Rate | Numerator | Denominator | Rate | Numerator | Denominator | Rate |

Low SEP | 65–74 | 1675 | 70,197 | 2.39% | 2567 | 94,383 | 2.72% | 4242 | 164,580 | 2.58% |

75–84 | 1180 | 50,525 | 2.34% | 2297 | 75,635 | 3.04% | 3477 | 126,160 | 2.76% | |

85 or above | 424 | 16,742 | 2.53% | 896 | 32,913 | 2.72% | 1320 | 49,655 | 2.66% | |

total | 3279 | 137,464 | 2.39% | 5760 | 202,931 | 2.84% | 9039 | 340,395 | 2.66% | |

Middle & high SEP | 65–74 | 2544 | 156,522 | 1.63% | 4163 | 167,895 | 2.48% | 6707 | 324,417 | 2.07% |

75–84 | 1478 | 69,352 | 2.13% | 2713 | 87,697 | 3.09% | 4191 | 157,049 | 2.67% | |

85 or above | 500 | 22,154 | 2.26% | 1032 | 35,656 | 2.89% | 1532 | 57,810 | 2.65% | |

total | 4522 | 248,028 | 1.82% | 7908 | 291,248 | 2.72% | 12,430 | 539,276 | 2.30% | |

Total | 7801 | 385,492 | 2.02% | 13,668 | 494,179 | 2.77% | 21,469 | 879,671 | 2.44% | |

BMI documentation | ||||||||||

Male | Female | Total | ||||||||

SEP | Age | Numerator | Denominator | Rate | Numerator | Denominator | Rate | Numerator | Denominator | Rate |

Low SEP | 65–74 | 53,898 | 64,758 | 83.23% | 70,201 | 85,632 | 81.98% | 124,099 | 150,390 | 82.52% |

75–84 | 40,220 | 46,809 | 85.92% | 57,509 | 69,604 | 82.62% | 97,729 | 116,413 | 83.95% | |

85 or above | NA | NA | NA | NA | NA | NA | NA | NA | NA | |

total | 94,118 | 111,567 | 84.36% | 127,710 | 155,236 | 82.27% | 221,828 | 266,803 | 83.14% | |

Middle & high SEP | 65–74 | 125,290 | 160,318 | 78.15% | 137,598 | 174,765 | 78.73% | 262,888 | 335,083 | 78.45% |

75–84 | 61,741 | 74,009 | 83.42% | 77,274 | 94,670 | 81.62% | 139,015 | 168,679 | 82.41% | |

85 or above | NA | NA | NA | NA | NA | NA | NA | NA | NA | |

total | 187,031 | 234,327 | 79.82% | 214,872 | 269,435 | 79.75% | 401,903 | 503,762 | 79.78% | |

Total | 281,149 | 345,894 | 81.28% | 342,582 | 424,671 | 80.67% | 623,731 | 770,565 | 80.94% | |

Underweight | ||||||||||

Male | Female | Total | ||||||||

SEP | Age | Numerator | Denominator | Rate | Numerator | Denominator | Rate | Numerator | Denominator | Rate |

Low SEP | 65–74 | 6122 | 53,898 | 11.36% | 6816 | 70,201 | 9.71% | 12,938 | 124,099 | 10.43% |

75–84 | 5127 | 40,220 | 12.75% | 6426 | 57,509 | 11.17% | 11,553 | 97,729 | 11.82% | |

85 or above | 2511 | 13,178 | 19.05% | 4453 | 22,450 | 19.84% | 6964 | 35,628 | 19.55% | |

total | 13,760 | 107,296 | 12.82% | 17,695 | 150,160 | 11.78% | 31,455 | 257,456 | 12.22% | |

Middle & high SEP | 65–74 | 11,220 | 125,261 | 8.96% | 19,388 | 137,576 | 14.09% | 30,608 | 262,837 | 11.65% |

75–84 | 7874 | 62,120 | 12.68% | 11,326 | 77,765 | 14.56% | 19,200 | 139,885 | 13.73% | |

85 or above | 3683 | 17,688 | 20.82% | 5686 | 25,961 | 21.90% | 9369 | 43,649 | 21.46% | |

total | 22,777 | 205,069 | 11.11% | 36,400 | 241,302 | 15.08% | 59,177 | 446,371 | 13.26% | |

Total | 36,537 | 312,365 | 11.70% | 54,095 | 391,462 | 13.82% | 90,632 | 703,827 | 12.88% | |

Weight loss | ||||||||||

Male | Female | Total | ||||||||

SEP | Age | Numerator | Denominator | Rate | Numerator | Denominator | Rate | Numerator | Denominator | Rate |

Low SEP | 65–74 | 2694 | 44,749 | 6.02% | 3637 | 57,831 | 6.29% | 6331 | 102,580 | 6.17% |

75–84 | 2417 | 36,760 | 6.58% | 4038 | 52,070 | 7.75% | 6455 | 88,830 | 7.27% | |

85 or above | 923 | 11,934 | 7.73% | 1904 | 19,601 | 9.71% | 2827 | 31,535 | 8.96% | |

total | 6034 | 93,443 | 6.46% | 9579 | 129,502 | 7.40% | 15,613 | 222,945 | 7.00% | |

Middle & high SEP | 65–74 | 4128 | 103,165 | 4.00% | 5706 | 114,904 | 4.97% | 9834 | 218,069 | 4.51% |

75–84 | 3398 | 58,820 | 5.78% | 5062 | 73,364 | 6.90% | 8460 | 132,184 | 6.40% | |

85 or above | 1408 | 16,582 | 8.49% | 2358 | 23,628 | 9.98% | 3766 | 40,210 | 9.37% | |

total | 8934 | 178,567 | 5.00% | 13,126 | 211,896 | 6.19% | 22,060 | 390,463 | 5.65% | |

Total | 14,968 | 272,010 | 5.50% | 22,705 | 341,398 | 6.65% | 37,673 | 613,408 | 6.14% |